34D.F 101.75 (+1.24%)
IT0003492391• Medical Diagnostics & Research• Diagnostics & Research
Intro Numbers Peers
  1. Home
  2. /
  3. All Stocks
  4. /
  5. 34D.F

Diasorin (34D.F) Competitor Comparison

We are evaluating the key criteria listed to compare Diasorin (34D.F) against its competitors in the Diagnostics & Research industry.

Market Capitalization

0 / 58

Gross Profits

0 / 52

Total Revenue

0 / 57

EBITDA

0 / 56

Free Cashflow

0 / 56

Quick Ratio

0 / 57

Earnings per Share

0 / 55

Dividend yield

0 / 8

Total Cash

0 / 57

Performance 3 years

0 / 58

Performance 5 years

0 / 58

Performance 10 years

0 / 58

Linearity 3 years

0 / 58

Linearity 5 years

0 / 58

Linearity 10 years

0 / 58

Total Rank

0 / 58

Dividend Rank

0 / 58

Valuation Rank

0 / 58

Piotroski Rank

0 / 58

Muliplier Rank

0 / 58

Linearity 10 years - 34D.F ranking 0 / 58

These are the competitors of Diasorin in the industry Diagnostics & Research ranked by linearity 10 years
1. Ortho Clinical Diagnostics Holdings OCDX
33.4
2. Anixa Biosciences ANIX
21.8
3. National Research NRC
20.54
4. Guardant Health GH
16.58
5. Illumina ILMN
9.62
6. Neogen NEOG
9.25
7. Olink Holding OLK
8.11
8. Fulgent Genetics FLGT
6.46
9. Inotiv NOTV
5.72
10. Global Cord Blood CO
5.67
11. DarioHealth DRIO
4.86
12. Exact Sciences EXAS
4.02
13. Sotera Health SHC
3.98
14. Pacific Biosciences of California PACB
3.82
15. Syneos Health SYNH
3.71
16. Bioventus BVS
3.38
17. Sera Prognostics SERA
3.34
18. Myriad Genetics MYGN
3.23
19. Co-Diagnostics CODX
3.21
20. Enzo Biochem ENZ
3.08
21. Charles River Laboratories CRL
2.64
22. Qiagen QGEN
2.62
23. Psychemedics PMD
2.61
24. NeoGenomics NEO
2.5
25. Exagen XGN
2.31
26. Aspira Womens Health AWH
2.28
27. CareDx CDNA
2.15
28. Twist Bioscience TWST
2.14
29. Meridian Bioscience VIVO
2.1
30. MDxHealth MDXH
1.99
31. MaxCyte MXCT
1.97
32. Biodesix BDSX
1.91
33. bioAffinity Technologies BIAF
1.9
34. Personalis PSNL
1.86
35. Quest Diagnostics DGX
1.8
36. Prenetics Global PRE
1.76
37. Organovo Holdings ONVO
1.66
38. Neuronetics STIM
1.62
39. Trinity Biotech TRIB
1.57
40. SeqLL SQL
1.42
41. Laboratory Corp of America Holdings LH
1.4
42. Icon ICLR
1.4
43. Interpace Biosciences IDXG
1.33
44. IQVIA Holdings IQV
1.25
45. PerkinElmer PKI
1.15
46. Precipio PRPO
1.09
47. DexCom DXCM
0.87
48. IDEXX Laboratories IDXX
0.87
49. Mettler-Toledo MTD
0.78
50. Agilent Technologies A
0.71
51. Danaher DHR
0.7
52. Thermo Fisher Scientific TMO
0.63
53. Waters WAT
0.63
54. Heska HSKA
0.52
55. Natera NTRA
0.43
56. RadNet RDNT
0.34
57. Lantheus Holdings LNTH
0.32
58. Medpace Holdings MEDP
0.22
Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.